Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference53 articles.
1. Darunavir: an overview of an HIV protease inhibitor developed to overcome drug resistance;Taiwo;AIDS Read,2007
2. Week 96 efficacy and safety of rilpivirine in treatment-naive HIV-1 patients in two Phase III randomized trials;Cohen;AIDS,2012
3. New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir;Hughes;Expert Opin. Pharmacother.,2009
4. Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial;Wilkin;AIDS Res. Hum. Retroviruses,2011
5. Integrase inhibitors: a new treatment option for patients with human immunodeficiency virus infection;Correll;Pharmacotherapy,2008
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献